Le. Hammarstrom et al., ENDOSCOPIC TREATMENT OF BILE-DUCT CALCULI IN PATIENTS WITH GALLBLADDER IN-SITU - LONG-TERM OUTCOME AND FACTORS PREDICTIVE OF RECURRENT SYMPTOMS, Scandinavian journal of gastroenterology, 31(3), 1996, pp. 294-301
Background: Whether endoscopic sphincterotomy (EST) in elderly and/or
high-risk patients with common bile duct calculi (CBD) and the gallbla
dder in situ should be followed by routine cholecystectomy is still a
subject of controversy. Methods: To identify factors predictive of sub
sequent biliary tract symptoms after EST and bile duct clearance, we r
eviewed 265 patients with intact gallbladder and CBD calculi who were
considered for EST in our department from 1981 to 1992. in 15 of 265 p
atients endoscopic treatment was not carried out, and the records of 4
patients were missing. Results: Complete removal of all bile duct cal
culi failed in 27 patients (11%). Cholecystectomy was performed in 35
patients (16%) with cleared bile ducts 1-765 days (median, 60 days) af
ter EST, in spite of absence of recurrent symptoms from the biliary tr
act. The remaining 184 patients have been retrospectively followed up
for 14-150 months (median, 69 months). Cholecystectomy was required in
35 because of acute cholecystitis (n = 23) or biliary colic (n = 12).
Of the cholecystectomies 86% were performed within 24 months after ES
T and only one after 4 years of follow-up. Increased frequency of chol
ecystectomy was found in patients with complete opacification of the g
allbladder at endoscopic cholangiography (p = 0.005). This was especia
lly evident in patients younger than 80 years (p = 0.002). Cholecystec
tomy was also required more often in patients with gallbladder calculi
(p = 0.02). The risk of cholangitis in patients without recurrent sto
nes was higher in those with juxtapapillary diverticula (p = 0.02). Fi
fty-nine patients without and 17 with mild to moderate symptoms from t
he biliary tract died after a median time of 39 and 46 months, respect
ively. Seventy-three patients are alive, and 59 are symptom-free. Ten
patients have had and four still have complaints of mild to moderate b
iliary tract symptoms. They have been followed for up to 16-146 months
(median, 40 months). Conclusions: These findings confirm that endosco
pic treatment alone in this group of patients is a feasible treatment
principle. Recognition of the registered risk factors might be helpful
when selecting patients for subsequent cholecystectomy.